Baidu
map

带动周边国家共同进步——中国国家“一带一路心脏介入培训项目”进展新闻发布会召开

2017-09-18 邢辰 中华医学信息导报

9月16日,中国国家“一带一路心脏介入培训项目”进展新闻发布会在山西太原成功举办。此次会议不但回顾了“一带一路心脏介入培训项目”的发展历程、展望了项目的未来规划,并且举行了“一带一路心脏介入培训基地”的证书颁发仪式,以及与哈萨克斯坦洽谈下一步的合作事宜。



9月16日,中国国家“一带一路心脏介入培训项目”进展新闻发布会在山西太原成功举办。此次会议不但回顾了“一带一路心脏介入培训项目”的发展历程、展望了项目的未来规划,并且举行了“一带一路心脏介入培训基地”的证书颁发仪式,以及与哈萨克斯坦洽谈下一步的合作事宜。

出席此次会议的有:中国医师协会办公室兼联络部主任石丽英女士;中华医学会心血管病学分会主任委员葛均波院士,中华医学会心血管病学分会前任主任委员霍勇教授,上海市胸科医院方唯一教授,解放军总医院陈韵岱教授,广东省人民医院陈纪言教授,广西医科大学第一附属医院李浪教授,北京大学人民医院刘健教授(代表王伟民教授),新疆医科大学第一附属医院马依彤教授,哈尔滨医科大学附属第二医院于波教授,武汉亚洲心脏病医院苏曦教授,宁夏医科大学总医院贾绍斌教授,以及哈萨克斯坦顶尖的国家医学科学中心院长及重要专家。

石丽英:国家层面推动“一带一路”卫生交流合作



石丽英女士表示:随着国家“一带一路”战略的不断推进,医疗行业的“一带一路”建设既是国家战略的延伸和重要支撑,也将充实和发展我国与沿路国家经济合作与人文交流的内涵。2015年,国家卫生计生委出台了《推进“一带一路”卫生交流合作三年实施方案(2015—2017)》,为我国及“一带一路”国家卫生交流合作提供了明确的蓝图。为响应国家战略号召,中国医师协会、中国心血管健康联盟共同发起“一带一路心脏介入培训项目”,经国家卫生计生委国际合作司批准立项。

项目旨在促进沿线国家心血管医师培训和技能提高,帮扶沿线国家进行卫生领域能力建设和医疗体系建设,使我国先进的诊疗技术和成功的管理经验惠及沿线各国人民;加强与“一带一路”国家的医疗卫生行业交流合作,搭建医疗卫生交流合作平台;在增进国与国友谊的同时,带动我国医疗器械、药品、医疗培训等行业发展推动中国医疗产业走向国际;增强中国医疗在国际上的影响力,体现出中国作为一个负责任的大国对于全球卫生健康事业的重要使命,争取中国在全球医疗卫生领域的话语权,为中国未来积极参与全球治理奠定基础。

葛均波:“一带一路”项目一步一个脚印向前推动



葛均波院士对目前“一带一路”项目进展情况进行汇报,“一带一路”项目是个完全崭新的概念,因此需要不断摸索,从合作战略研究、执行方案制定、试点选择、落地实施、持续优化、进一步拓展和扩大,直至合作网络、机制、格局的形成和稳固等多方面进行考量。目前项目已取得初步的显着成效。

去年借印尼介入心脏病学会主席来华参加学术活动的契机,了解到对方希望我方帮助培训相关医疗人员的需求,达成初步合作方案,印尼同意先推荐5名心血管医师来华进行为期1年左右的基础冠心病介入培训,若取得理想效果,再进一步扩大合作。“一带一路项目”的首个试点国家就此选定。

今年5月,这5名学员正式来华,在葛均波院士、钱菊英教授、张峰教授、霍勇教授、李建平教授、王伟民教授、刘健教授、陈纪言教授、杨峻青教授、李浪教授、曾晓聪教授等专家的指导和安排下,进入复旦大学附属中山医院、北京大学第一医院、北京大学人民医院、广东省人民医院、广西医科大学第一附属医院开始接受培训。直至目前,培训稳而有序地进行,借助中国心血管远程教育学院开展了视频互动授课以及病例讲解讨论、查房、手术观摩、临床实践、参与科研学术等活动。导师全程评估学员对知识和技能的掌握及参与培训的态度,并给予打分。通过考核的学员将获得中国医师协会颁发的结业证书。

6月,在陈韵岱教授和石丽英主任的推动下,解放军总医院的“一带一路”工作正式启动,同期举办“第22届Insight解放军总医院心脏中心亚太冠心病介入诊疗提高班,吸引10余位外籍医师学员。

7月,葛均波院士等复旦大学附属中山医院领导一道接待了前来参观和学习的三十多个国家的50多位“一带一路”代表,举行内容丰富的经验交流会。

8月,特在新疆设立“国家一带一路心血管培训项目新疆合作办公室”。至此,我国已建立了两个“一带一路”中心:新疆乌鲁木齐,主要辐射中亚各国;广西南宁,主要辐射东盟十国。

经过前期的试点工作,印尼学会对在华培训表示十分感谢和满意,继而又推荐了新学员来华。他们的主要诉求是学习复杂冠脉介入、左主干病变、分叉病变、CTO介入、旋磨术和IVUS。我们正在协调将这些学员安排在解放军总医院、武汉亚洲心脏病医院、上海市胸科医院、哈尔滨医科大学附属第二医院和宁夏医科大学总医院。

霍勇:一带一路项目未来可期



霍勇教授在畅谈项目未来发展时指出:经过初步探索,目前我们已经基本掌握了整个办理外国医师来华培训的流程以及难点,并找到了合适的解决办法。接下来,我们希望在国家卫生计生委和中国医师协会的领导下,把项目工作常态化、制度化并且进一步拓展和扩大,更好的支持卫生计生委的“一带一路”战略。

第一,我们希望以少数国家合作为突破,找到可行和高效的方法,从而逐步扩展并带动“一带一路”更多国家的全面合作。

第二,我们希望从介入相关内容扩展到整个心血管行业的合作与发展,并且在有条件的情况下,通过培训骨干人才逐步协助当地国家建立自身的心血管医疗体系。

第三,我们计划委派我国专家前往沿线国家参会并进行专题讲座、手术演示、带教查房、科研辅导、培训指导等现场帮教活动。

第四,我们希望通过各种区域性的学术平台建立多层次的学术交流活动,使得相关国家受训人才持续与中国专家进行互动交流,得到医疗水平的持续提高。

第五,随着项目的拓展,我们将继续建设和扩大人才培养培训基地,并邀请经验丰富的导师进行留学生带教分享以及举办导师培训班。

我国与“一带一路”国家在心血管介入领域的卫生合作方式已初步形成。在国家卫生计生委和中国医师协会的领导下,我们将进一步发扬光大,支持国家“一带一路”战略,支持卫生计生委医疗行业的“一带一路”,我们期待着合作网络的进一步扩大、合作机制的进一步稳固、和心血管领域全方位合作格局的形成。

哈萨克斯坦顶级专家分享合作意向



我国心血管行业的发展模式让哈萨克斯坦看到了一丝曙光,那是一种值得学习和借鉴的样本,他们希望将这一模式在自己的国家得到推广,甚至进一步扩大至整个中亚。

合作的重中之重是心血管介入培训和胸痛中心建设,以及高血压、电生理、心律失常培训、心血管病护理及技术培训,建立心血管远程教育学院。

哈萨克斯坦国家级专家对此次发布会高度赞赏,表示此行非常值得和圆满,洽谈内容全面丰富,回国后会向国家和医院汇报,推动落实下一步的具体工作。

“一带一路心脏介入培训基地”证书颁发



在此次发布会上,石丽英主任以及葛均波院士和霍勇教授共同为目前11家“一带一路心脏介入培训基地”颁发基地证书,它们分别是:北京大学第一医院、北京大学人民医院、复旦大学附属中山医院、广东省人民医院、广西医科大学第一附属医院、武汉亚洲心脏病医院、新疆医科大学第一附属医院、解放军总医院、上海市胸科医院哈尔滨医科大学附属第二医院宁夏医科大学总医院。

总结

石丽英主任在总结时表示:项目会继续坚持和平合作、开放包容、互学互鉴、互利共赢的核心价值理念,在逐步提高“一带一路”沿线国家介入诊疗技术和水平的同时,探索国际卫生交流的合作方法和模式,为后续开展全面的心血管领域国际交流打下坚实的基础,促进我国及沿线国家卫生事业发展,为打造“健康一带一路”作出应有贡献。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2052608, encodeId=6fa72052608aa, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Sat May 19 14:32:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740247, encodeId=5c581e4024764, content=<a href='/topic/show?id=701c51403d1' target=_blank style='color:#2F92EE;'>#心脏介入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51403, encryptionId=701c51403d1, topicName=心脏介入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=976b34689519, createdName=ms9474365431325850, createdTime=Sat May 19 13:32:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573519, encodeId=cd5615e3519ae, content=<a href='/topic/show?id=bf071932889' target=_blank style='color:#2F92EE;'>#一带一路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19328, encryptionId=bf071932889, topicName=一带一路)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb8815894510, createdName=steven_u7, createdTime=Wed Sep 20 13:32:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245795, encodeId=497f245e9556, content=不错的文章值得推荐一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Tue Sep 19 23:04:47 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245590, encodeId=4a6f245590f7, content=好好看一下有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Sep 19 07:31:37 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245559, encodeId=d62d245559bf, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Sep 19 06:53:44 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245513, encodeId=db0c24551329, content=学习了.好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Sep 19 05:08:39 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
    2018-05-19 宋威
  2. [GetPortalCommentsPageByObjectIdResponse(id=2052608, encodeId=6fa72052608aa, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Sat May 19 14:32:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740247, encodeId=5c581e4024764, content=<a href='/topic/show?id=701c51403d1' target=_blank style='color:#2F92EE;'>#心脏介入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51403, encryptionId=701c51403d1, topicName=心脏介入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=976b34689519, createdName=ms9474365431325850, createdTime=Sat May 19 13:32:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573519, encodeId=cd5615e3519ae, content=<a href='/topic/show?id=bf071932889' target=_blank style='color:#2F92EE;'>#一带一路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19328, encryptionId=bf071932889, topicName=一带一路)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb8815894510, createdName=steven_u7, createdTime=Wed Sep 20 13:32:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245795, encodeId=497f245e9556, content=不错的文章值得推荐一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Tue Sep 19 23:04:47 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245590, encodeId=4a6f245590f7, content=好好看一下有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Sep 19 07:31:37 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245559, encodeId=d62d245559bf, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Sep 19 06:53:44 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245513, encodeId=db0c24551329, content=学习了.好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Sep 19 05:08:39 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2052608, encodeId=6fa72052608aa, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Sat May 19 14:32:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740247, encodeId=5c581e4024764, content=<a href='/topic/show?id=701c51403d1' target=_blank style='color:#2F92EE;'>#心脏介入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51403, encryptionId=701c51403d1, topicName=心脏介入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=976b34689519, createdName=ms9474365431325850, createdTime=Sat May 19 13:32:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573519, encodeId=cd5615e3519ae, content=<a href='/topic/show?id=bf071932889' target=_blank style='color:#2F92EE;'>#一带一路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19328, encryptionId=bf071932889, topicName=一带一路)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb8815894510, createdName=steven_u7, createdTime=Wed Sep 20 13:32:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245795, encodeId=497f245e9556, content=不错的文章值得推荐一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Tue Sep 19 23:04:47 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245590, encodeId=4a6f245590f7, content=好好看一下有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Sep 19 07:31:37 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245559, encodeId=d62d245559bf, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Sep 19 06:53:44 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245513, encodeId=db0c24551329, content=学习了.好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Sep 19 05:08:39 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2052608, encodeId=6fa72052608aa, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Sat May 19 14:32:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740247, encodeId=5c581e4024764, content=<a href='/topic/show?id=701c51403d1' target=_blank style='color:#2F92EE;'>#心脏介入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51403, encryptionId=701c51403d1, topicName=心脏介入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=976b34689519, createdName=ms9474365431325850, createdTime=Sat May 19 13:32:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573519, encodeId=cd5615e3519ae, content=<a href='/topic/show?id=bf071932889' target=_blank style='color:#2F92EE;'>#一带一路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19328, encryptionId=bf071932889, topicName=一带一路)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb8815894510, createdName=steven_u7, createdTime=Wed Sep 20 13:32:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245795, encodeId=497f245e9556, content=不错的文章值得推荐一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Tue Sep 19 23:04:47 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245590, encodeId=4a6f245590f7, content=好好看一下有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Sep 19 07:31:37 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245559, encodeId=d62d245559bf, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Sep 19 06:53:44 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245513, encodeId=db0c24551329, content=学习了.好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Sep 19 05:08:39 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
    2017-09-19 131****2916

    不错的文章值得推荐一下

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2052608, encodeId=6fa72052608aa, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Sat May 19 14:32:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740247, encodeId=5c581e4024764, content=<a href='/topic/show?id=701c51403d1' target=_blank style='color:#2F92EE;'>#心脏介入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51403, encryptionId=701c51403d1, topicName=心脏介入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=976b34689519, createdName=ms9474365431325850, createdTime=Sat May 19 13:32:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573519, encodeId=cd5615e3519ae, content=<a href='/topic/show?id=bf071932889' target=_blank style='color:#2F92EE;'>#一带一路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19328, encryptionId=bf071932889, topicName=一带一路)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb8815894510, createdName=steven_u7, createdTime=Wed Sep 20 13:32:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245795, encodeId=497f245e9556, content=不错的文章值得推荐一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Tue Sep 19 23:04:47 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245590, encodeId=4a6f245590f7, content=好好看一下有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Sep 19 07:31:37 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245559, encodeId=d62d245559bf, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Sep 19 06:53:44 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245513, encodeId=db0c24551329, content=学习了.好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Sep 19 05:08:39 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
    2017-09-19 忠诚向上

    好好看一下有意义

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2052608, encodeId=6fa72052608aa, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Sat May 19 14:32:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740247, encodeId=5c581e4024764, content=<a href='/topic/show?id=701c51403d1' target=_blank style='color:#2F92EE;'>#心脏介入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51403, encryptionId=701c51403d1, topicName=心脏介入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=976b34689519, createdName=ms9474365431325850, createdTime=Sat May 19 13:32:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573519, encodeId=cd5615e3519ae, content=<a href='/topic/show?id=bf071932889' target=_blank style='color:#2F92EE;'>#一带一路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19328, encryptionId=bf071932889, topicName=一带一路)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb8815894510, createdName=steven_u7, createdTime=Wed Sep 20 13:32:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245795, encodeId=497f245e9556, content=不错的文章值得推荐一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Tue Sep 19 23:04:47 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245590, encodeId=4a6f245590f7, content=好好看一下有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Sep 19 07:31:37 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245559, encodeId=d62d245559bf, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Sep 19 06:53:44 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245513, encodeId=db0c24551329, content=学习了.好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Sep 19 05:08:39 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
    2017-09-19 明月清辉

    谢谢分享.学习了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2052608, encodeId=6fa72052608aa, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Sat May 19 14:32:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740247, encodeId=5c581e4024764, content=<a href='/topic/show?id=701c51403d1' target=_blank style='color:#2F92EE;'>#心脏介入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51403, encryptionId=701c51403d1, topicName=心脏介入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=976b34689519, createdName=ms9474365431325850, createdTime=Sat May 19 13:32:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573519, encodeId=cd5615e3519ae, content=<a href='/topic/show?id=bf071932889' target=_blank style='color:#2F92EE;'>#一带一路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19328, encryptionId=bf071932889, topicName=一带一路)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb8815894510, createdName=steven_u7, createdTime=Wed Sep 20 13:32:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245795, encodeId=497f245e9556, content=不错的文章值得推荐一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Tue Sep 19 23:04:47 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245590, encodeId=4a6f245590f7, content=好好看一下有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Sep 19 07:31:37 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245559, encodeId=d62d245559bf, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Sep 19 06:53:44 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245513, encodeId=db0c24551329, content=学习了.好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Sep 19 05:08:39 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
    2017-09-19 1ddf0692m34(暂无匿称)

    学习了.好文章

    0

相关资讯

推进“一带一路”卫生合作 打造“健康丝绸之路”

国家卫生计生委认真贯彻落实党中央、国务院共建“一带一路”的重大决策部署,于2015年发布《关于推进“一带一路”卫生交流合作三年实施方案(2015-2017)》(以下简称《实施方案》),努力打造“健康丝绸之路”,取得了初步成效。

国家卫计委侯岩:全国超27个省出台健康产业发展规划

8月14日,在国家卫生计生委举行的“一带一路”暨“健康丝绸之路”高级别研讨会有关情况媒体吹风会上,国家卫生计生委规划与信息司司长侯岩介绍了我国健康产业发展的相关情况

Baidu
map
Baidu
map
Baidu
map